Medicare Enrolled
Dr. Hassan Shukri-Mahmod, MD
Optician · East Syracuse, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shukri-Mahmod from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shukri-Mahmod?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shukri-Mahmod
Dr. Hassan Shukri-Mahmod is an optician specialist in East Syracuse, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Shukri-Mahmod performed 2,919 Medicare services across 1,591 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shukri-Mahmod received a total of $13,738 from 67 pharmaceutical and/or device companies across 730 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shukri-Mahmod is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 27% volume in NY
$13,738 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,919
Medicare services
Top 27% in NY for optician
1,591
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~154 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
779 | $60 | $225 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
507 | $72 | $250 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 362 | $74 | $366 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
358 | $38 | $140 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
357 | $38 | $357 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
202 | $87 | $300 |
| New patient office visit, complex (60-74 min) | 117 | $151 | $543 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
93 | $208 | $725 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
69 | $123 | $451 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
45 | $260 | $875 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $119 | $410 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $107 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,738
Total received (2018-2024)
Avg $1,963/year across 7 years
Top 11% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
730
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,476 (98.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$262 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,920
2023
$2,500
2022
$1,859
2021
$791
2020
$472
2019
$1,982
2018
$2,214
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$1,346
ABBVIE INC.
$428
Lilly USA, LLC
$194
SK Life Science, Inc.
$177
PFIZER INC.
$168
EMD Serono, Inc.
$154
UCB, Inc.
$143
Neurocrine Biosciences, Inc.
$139
Otsuka America Pharmaceutical, Inc.
$133
TG Therapeutics, Inc.
$107
Kyowa Kirin, Inc.
$95
Amneal Pharmaceuticals LLC
$92
Novartis Pharmaceuticals Corporation
$90
Alexion Pharmaceuticals, Inc.
$80
Lundbeck LLC
$67
MDD US Operations, LLC
$66
Eisai Inc.
$50
Biogen, Inc.
$46
Sumitomo Pharma America, Inc.
$43
CATALYST PHARMACEUTICALS, INC.
$40
Celgene Corporation
$39
Genentech USA, Inc.
$33
Axsome Therapeutics, Inc.
$33
Teva Pharmaceuticals USA, Inc.
$31
ARGENX US, INC.
$29
Novo Nordisk Inc
$25
Takeda Pharmaceuticals U.S.A., Inc.
$22
MITSUBISHI TANABE PHARMA AMERICA, INC.
$21
GENZYME CORPORATION
$16
Avadel CNS Pharmaceuticals, LLC
$15
Top 3 companies account for 50.2% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$1,414
Biogen, Inc.
$1,237
ABBVIE INC.
$931
EMD Serono, Inc.
$771
AbbVie Inc.
$692
Teva Pharmaceuticals USA, Inc.
$687
Amgen Inc.
$442
GENZYME CORPORATION
$442
UCB, Inc.
$408
PFIZER INC.
$379
Alexion Pharmaceuticals, Inc.
$359
Amneal Pharmaceuticals LLC
$346
SK Life Science, Inc.
$325
Neurocrine Biosciences, Inc.
$318
Lilly USA, LLC
$314
Supernus Pharmaceuticals, Inc.
$311
Novartis Pharmaceuticals Corporation
$307
Kyowa Kirin, Inc.
$303
Genentech USA, Inc.
$294
Lundbeck LLC
$270
Sunovion Pharmaceuticals Inc.
$232
Otsuka America Pharmaceutical, Inc.
$198
US WorldMeds, LLC
$195
ARGENX US, INC.
$176
JAZZ PHARMACEUTICALS INC.
$130
Eisai Inc.
$127
Medtronic, Inc.
$112
Sumitomo Pharma America, Inc.
$110
TG Therapeutics, Inc.
$107
Celgene Corporation
$96
MDD US Operations, LLC
$95
ACADIA Pharmaceuticals Inc
$93
Janssen Pharmaceuticals, Inc
$85
Avanir Pharmaceuticals, Inc.
$80
Mallinckrodt LLC
$78
ARBOR PHARMACEUTICALS, INC.
$76
Takeda Pharmaceuticals U.S.A., Inc.
$65
Biohaven Pharmaceuticals, Inc.
$65
AbbVie, Inc.
$63
Mallinckrodt Hospital Products Inc.
$63
Axsome Therapeutics, Inc.
$61
Novo Nordisk Inc
$58
Allergan Inc.
$58
Biohaven Pharmaceutical Holding Company Ltd.
$54
Adamas Pharmaceuticals, Inc.
$51
Promius Pharma LLC
$50
Impax Laboratories, Inc.
$48
Azurity Pharmaceuticals, Inc.
$47
Vertical Pharmaceuticals, LLC
$41
Acorda Therapeutics, Inc
$41
CATALYST PHARMACEUTICALS, INC.
$40
MITSUBISHI TANABE PHARMA AMERICA, INC.
$40
Assertio Therapeutics, Inc.
$37
Upsher-Smith Laboratories LLC
$36
IMPEL PHARMACEUTICALS INC.
$31
ANI Pharmaceuticals, Inc.
$30
TG THERAPEUTICS, INC.
$28
Avion Pharmaceuticals
$25
Xeris Pharmaceuticals, Inc.
$25
Banner Life Sciences, LLC
$24
Alnylam Pharmaceuticals Inc.
$22
Mylan Specialty L.P.
$20
Boston Scientific Corporation
$15
Avadel CNS Pharmaceuticals, LLC
$15
Collegium Pharmaceutical, Inc.
$14
Horizon Therapeutics plc
$14
Bayer HealthCare Pharmaceuticals Inc.
$14
Top 3 companies account for 26.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · ATLANTIS ANTERIOR CERVICAL PLATE SYSTEM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · CAMBIA · COMIRNATY · CREXONT · DUOPA · Dhivy · Duopa · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · FIRDAPSE · Fycompa · GAMMAGARD · GLATIRAMER ACETATE · GOCOVRI · GRAFTONAND GRAFTON PLUSDEMINERALIZED BONE MATRIX (DBM) · Gocovri · HYQVIA · Horizant · INBRIJA · INFINITY · INGREZZA · INTELLIS ADAPTIVESTIM · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KOSELUGO · KYNMOBI · LEMTRADA · LUMRYZ · LYRICA · Leqembi · MAVENCLAD · MAYZENT · METHYLPHENIDATE 72 · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · Ozempic · PAXLOVID · PLEGRIDY · POMPE - DISEASE · PURIFIED CORTROPHIN GEL · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · RYTARY · Rebif · Rybelsus · Rystiggo · SKYCLARYS · SOLIRIS · SUNOSI · Sunosi · TECFIDERA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VERCISE · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Wegovy · XCOPRI · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
359
Per 100K population
76.1
County median income
$74,740
Nearest hospital
ST JOSEPH'S HOSPITAL HEALTH CENTER
5.7 mi
5.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shukri-Mahmod is a clinical cardiology specialist, with above-average Medicare volume (top 27% in NY), with low-engagement industry engagement in the top 11% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shukri-Mahmod experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Shukri-Mahmod performed 779 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shukri-Mahmod receive payments from pharmaceutical companies?
Yes. Dr. Shukri-Mahmod received a total of $13,738 from 67 companies across 730 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shukri-Mahmod's costs compare to other opticians in East Syracuse?
Dr. Shukri-Mahmod's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shukri-Mahmod) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in East Syracuse
Browse opticians in East Syracuse ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NY
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NY
Which NY opticians receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology